Add like
Add dislike
Add to saved papers

[A cross-sectional study on HIV/AIDS "90-90-90" treatment target in Shandong province, 2015].

Objective: To analyze the status and its factors associated with HIV/AIDS- "90-90-90" -treatment-target in Shandong province, China. Methods: Data regarding testing, treatment on HIV/AIDS in Shandong province by December 31, 2015 was collected. Chi-square test and logistic regression model were used to analyze related factors associated with the "90-90-90" -treatment-target. Results: Of the 11 700 estimated HIV/AIDS, 61.2 % were diagnosed, of whom 74.4 % had received Highly active antiretroviral therapy (HAART) . More than 80 % of the HIV/AIDS on HAART reached the criteria on viral suppression. HIV/AIDS infected by homosexual contacts were less likely to seek for diagnosis ( P <0.05). HIV/AIDS lived in Qingdao city ( OR =1.30, 95 %CI : 1.05-1.60), Yantai city ( OR =1.53, 95 %CI : 1.02-2.31) and Weihai city ( OR =1.96, 95 %CI : 1.07-3.58) were more likely to receive HAART. HIV/AIDS patients that infected through homosexual or ( OR =0.12, 95 %CI :0.06-0.24) or heterosexual contacts ( OR =0.13, 95 %CI : 0.07-0.26), through injecting drug use ( OR =0.08,95 %CI : 0.03-0.17) or being diagnosed at the custodial institutions ( OR =0.29, 95 %CI : 0.21-0.41) were less likely to receive HAART. HIV/AIDS patients who received HAART at medical institutions ( OR =1.81, 95 %CI : 1.05-3.47) were more likely to meet the level of Viral load (VL) suppression. However, those who were infected through homosexual ( OR =0.43, 95 %CI : 0.25-0.75) or heterosexual contacts ( OR =0.49, 95 %CI : 0.28-0.81) or diagnosed at the custodial institutions ( OR =0.48, 95 %CI : 0.28-0.80) were less likely to meet the criteria set for VL suppression. Conclusions: There was a gap between the status of testing/treatment and the target on HIV/AID "90-90-90" -treatment,especially on the target set for testing, in Shandong Province. Both HIV testing and comprehensive care services need to be strengthened.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app